Swift Treatment using transcranial magnetic stimulation and Outcome Prediction in Depression - STOP-D

niversitätsklinikum der RWTH Aachen0 sites44 target enrollmentFebruary 4, 2022

Overview

No summary available.

Registry

who.int

Start Date

February 4, 2022

End Date

TBD

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

niversitätsklinikum der RWTH Aachen

•Adult wmen and women between 18 and 80 years\-old with a current nonpsychotic depression (either as part of a major depressive disorder or bipolar disorder) according to ICD\-10; at least 20 points on the 17\-item Hamilton\-scale at baseline; nonresponse to at least one antidepressant; stable psychiatric medication in the last two weeks; sufficient German language skills; written informed consent; in case of legal guardianship also informed consent of the legal guardian

•Known seizure disorder (epilepsia) or confounding neurological disease, dementia or cognitive impairment; other somatic disease that interfers with the investigation or has an effect on the investigated parameters; current alcohol or drug abuse Drogen\-, Alkohol\- oder Schmerzmittelabusus; pregnancy or lactation; electromagnetic or metallic medical devices in or connected to the body (e.g., pacemakers, drug pumps, cochlea implants); metal in the body (e.g., screws due to fractures, shards of metal, metal prostheses, non\-MR\-compatible vascular clips); previous heart and/or brain surgery; widespread tattoos; previous treatment with TMS